US Patent Issued to Sangamo Therapeutics on June 16 for "Methods and compositions for treating Huntington's Disease" (California Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,861, issued on June 16, was assigned to Sangamo Therapeutics Inc. (Richmond, Calif.).

"Methods and compositions for treating Huntington's Disease" was invented by Jeffrey C. Miller (Brisbane, Calif.), Edward J. Rebar (Brisbane, Calif.) and H. Steve Zhang (Brisbane, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions comprising non-naturally occurring zinc finger domains, fusion proteins comprising these zinc finger domains, polynucleotides encoding these proteins, cells expressing these proteins and pharmaceutical compositions comprising these proteins or polynucleotides as well as methods of modifying an Htt gene...